N/A N=75 Treatment

REACH Pilot Study (Rehabilitation Enhancing Aging Through Connected Health)

Mobility Limitation

Bottom Line

View on ClinicalTrials.gov: NCT02580409 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2025

Primary outcome: Primary: Change in Late Life Function and Disability Index (Function Domain Only) — 1.67 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Exercise Intervention (Behavioral)
Age: Older Adult · 65+ yrs
Sex: All
Sponsor: Spaulding Rehabilitation Hospital
Primary completion: May 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Late Life Function and Disability Index (Function Domain Only)	1.67	—

Summary

Rehabilitation Enhancing Aging through Connected Health, REACH, is designed to evaluate the benefits of a novel rehabilitative care program on physical function utilizing mobile health technology to deliver patient centered care more efficiently and health care utilization after one year of follow up.

Eligibility Criteria

Inclusion Criteria

Ages 65-95 years
Able to understand and communicate in English
Difficulty or task modification with walking ½ mile (6 blocks) or climbing one flight of stairs
Ability to continuously walk 400 m in less than 15 minutes without stopping for more than a minute at a time, sitting, leaning, or the help of another person
Lives in a zip code within 10 mile radius of Spaulding Cambridge Facility
Baseline Short Physical Performance Battery (SPPB) scores from 3-12 with <20% of SPPB scores in the 11-12 range

Exclusion Criteria

Presence of a terminal disease (e.g. receiving hospice services, metastatic cancer)
Major surgery or Myocardial Infarction in the last 6 months
Planned major surgery (e.g. joint replacement)
Planned move from the Boston area within 1.5 years
Mini-mental state exam (MMSE) score <20
Major medical problems interfering with safe and successful testing (examples may include: history hip replacement with recurrent dislocation, uncontrolled hypertension, use of supplemental oxygen)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02580409). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.